Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2010
10/13/2010CN101856372A Preparation method of agrocybe intracellular polysaccharide with immunity-enhancing activity
10/13/2010CN101856371A Medicinal composition for improving immunity
10/13/2010CN101856370A Medicine combination capable of regulating immunity
10/13/2010CN101856362A Pharmaceutical compositions for the treatment of asthma
10/13/2010CN101856347A Extract of leontopodic acid plant and application of active ingredients thereof in treating hepatitis
10/13/2010CN101434661B Lichee polysaccharide, and extracting method and use thereof
10/13/2010CN101396371B Content determination method of Tibet crude-medicine processing material and new use thereof
10/13/2010CN101152170B Capsule containing pseudoephedrine and method for preparing the same
10/13/2010CN101081843B Non-nucleoside reverse transcriptase inhibitors
10/13/2010CN101041629B New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812136 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812029 such as N4-[(2,2-Dimethyl-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]-2,4-pyrimidinediamine; Glomerulonephritis; rheumatoid arthritis; systemic lupus erythematosis; multiple sclerosis
10/12/2010US7812004 For modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine; anticancer agents; dietary fibre effects, improved mineral absorption (calcium and magnesium), for treating osteoporosis
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811816 Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cell
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2419552C Substituted pyrazoles
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2376305C Sulfonamide and sulfamide substituted imidazoquinolines
10/12/2010CA2375599C Probiotic compositions comprising e. coli and volatile fractions of plant extracts
10/12/2010CA2327528C Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
10/12/2010CA2308765C The use of an ox-2 protein or nucleic acid in immunomodulation
10/12/2010CA2198586C Mutant enterotoxin effective as a non-toxic oral adjuvant
10/07/2010WO2010113925A1 Composition for alleviating ultraviolet radiation-induced damage
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113148A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
10/07/2010WO2010112497A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
10/07/2010WO2010112461A1 Oxadiazole derivatives
10/07/2010WO2010111910A1 Synthetic peptide and uses thereof
10/07/2010WO2010111807A1 A polysaccharide liposome, the preparation method and use of it
10/07/2010WO2009100505A8 Immunogenic peptides and their use in transplantation
10/07/2010US20100256230 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
10/07/2010US20100256223 Oligonucleotides for modulating target rna activity
10/07/2010US20100256213 Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide
10/07/2010US20100256211 Inhibition of Chronic Tissue Transplant Rejection
10/07/2010US20100256202 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
10/07/2010US20100256172 Heteroaryls and uses thereof
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256143 Pharmaceutical compounds
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256132 Il-12 modulatory compounds
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256118 Novel adenine compound and use thereof
10/07/2010US20100256081 Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
10/07/2010US20100256077 Core 2GlcNAc-T inhibitors
10/07/2010US20100256039 Control of copolymer compositions
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255507 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255130 Aloe preparation for skin enhancement
10/07/2010US20100255102 Sterilization of dispersions of nanoparticulate active agents with gamma radiation
10/07/2010US20100255087 oral pharmaceutical composition
10/07/2010US20100255043 Methods for preparing T-cells for cell therapy
10/07/2010US20100255039 Induction of tolerance to egg proteins
10/07/2010US20100255034 Streptococcus Pyogenes Antigens
10/07/2010US20100255031 truncated l1 protein of human papillomavirus type 16
10/07/2010US20100255030 Avirulent, immunogenic flavivirus chimeras
10/07/2010US20100255024 Composition for inhibition of transplant rejection containing the phellinus linteus mycellia extract as an active ingredient
10/07/2010US20100255022 Vaccine against clostridium perfringens
10/07/2010US20100255021 Truncated l1 protein of human papillomavirus type 6
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255009 Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
10/07/2010US20100255003 Immune Disease Medicament Comprising a Modulator of the Binding Between a Heparin Bindin Domain of Thrombospondin-1 and a Beta1 Integrin
10/07/2010US20100254995 Polypeptides, antibody variable domains and antagonists
10/07/2010US20100254993 Human monoclonal antibodies against human il-4
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254978 Antibody molecules having specificity for human ox40
10/07/2010US20100254974 Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
10/07/2010US20100254971 Method for Diagnosing Prognosing Inflammatory Bowel Disease and Crohn's Disease
10/07/2010US20100254940 Compositions and Methods for Regulating an Immune Response in a Subject
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756762A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
10/07/2010CA2755928A1 Oxadiazole derivatives
10/06/2010EP2236608A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
10/06/2010EP2236605A1 Human anti- 9 integrin antibody
10/06/2010EP2236521A1 Y-type polyethylene glycol modified g-csf and preparation method and use thereof
10/06/2010EP2236518A2 Humaneered anti-factor B antibody
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236147A1 Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly
10/06/2010EP2235037A1 Steroid derivatives acting as glucocorticosteroid receptor agonists
10/06/2010EP2235018A1 Pharmaceutically acceptable salts of methyl (3-{ ýý3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl¨(3- morpholin-4-ylpropyl) amino¨methyl }phenyl) acetate and their use in therapy
10/06/2010EP2234669A1 Design and selection of medicaments that modulate the function and activity of interleukin 13
10/06/2010EP1689726B1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
10/06/2010EP1565158B1 Oxazolidinones for pharmaceutical use in skin pathologies, autoimmune disorders, photoimmunosuppression and graft rejection
10/06/2010EP1551449B1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
10/06/2010EP1513554B1 Cd16a binding proteins and use for the treatment of immune disorders
10/06/2010EP1513543B1 Fas peptide mimetics and uses thereof
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010CN1899438B Miao medicine powder for curing eczema and rubella
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 1172